Questions? Feedback? powered by Olark live chat software
Store   |   Nursing Careers   |   Search   |   Contact Us   |   Sign In   |   Join/Renew
Press Releases : 2015 Press Releases

Guidance for Managing Drug Withdrawal in Newborns Published by Leading Nursing Journal

Thursday, February 5, 2015  
Share |

Rise in Maternal Opiate Use Exposes Infants to

Withdrawal Symptoms, Birth Defects and Other Health Issues

 

Washington, DC, February 5, 2015 – With the rise of opiate drug use and overdose nationwide, nurses are observing an increase in maternal drug use during pregnancy. Between the years 2000 and 2009, the prevalence of infants diagnosed with drug withdrawal (or neonatal abstinence syndrome [NAS]) increased nearly three times and maternal opiate use increased about five times. Substance use during pregnancy is associated with birth defects, low birth weight, premature birth, seizures and neurobehavioral or cognitive defects.

 

In “Management of Neonatal Abstinence Syndrome in the Newborn Nursery,” Valarie Artigas, MSN, NNP-BC, wrote about managing neonatal withdrawal symptoms from maternal drug use during pregnancy. This article appears in the December 2014/January 2015 issue of Nursing for Women’s Health, the clinical practice journal of the Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN).

 

Newborns experience NAS as a result of their no longer being exposed to the addictive substance(s) they were exposed to in the womb. Essentially, infants are experiencing withdrawal symptoms and may need medical intervention. Clinical presentation for NAS is influenced by many factors, including the types of drugs used, the timing and amount of last drug use, and the metabolism of the drugs by newborns. Some infants may show withdrawal symptoms immediately after birth or others up to four days later.

Drug-exposed newborns begin a withdrawal process following birth, causing neurologic, gastrointestinal and autonomic nervous system symptoms. Generally, infants exposed to nicotine, alcohol or marijuana do not show withdrawal symptoms, but they may experience abnormal behaviors that normalize over time. Infants with NAS experience hyperirritability that can be exacerbated by overstimulation in their environment.

 

With maternal history playing a strong role in diagnosing and managing NAS, it’s important for nurses to review the maternal health record when a newborn shows withdrawal symptoms. Newborns’ behaviors and responses to interactions and their environment should also be assessed to determine the need for specific soothing techniques, such as a quiet environment with low lighting and soft voices. The newborn may also need clustering care and swaddling, pacifiers to promote self-soothing, frequent, smaller feedings, and vertical rocking to decrease hyperactivity. Clinical scoring tools can be used to measure the severity of withdrawal symptoms in infants to aid in deciding if medication is needed, such as oral morphine and methadone.

 

While there is ongoing debate, research has found shorter hospital stays and decreased need for medications when newborns and mothers are not separated. Family-centered care also promotes attachment between mothers and infants. However, infants needing medication are traditionally cared for in a hospital setting (and not at home) so that they can be monitored.

 

“Nurses serve a vital role in caring for infants who were exposed to drugs in utero,” said AWHONN’s CEO, Lynn Erdman, MN, RN, FAAN. “Nurses can help by working to develop a screening process and treatment guidelines to effectively identify and support these vulnerable mothers and infants.”

 

To support the ongoing clinical practice of nurses, AWHONN recently issued a new position statement entitled, “Criminalization of Pregnant Women with Substance Use Disorders.” The statement outlines AWHONN’s opposition to laws and other reporting requirements that result in incarceration or other punitive legal actions against women because of a substance abuse disorder in pregnancy. Further, the statement underscores the importance of universal screening and early identification of pregnant women with substance use disorders for the purpose of initiating referral for treatment and specialized prenatal care.

 

For media interviews, contact:

Kelly Mack for AWHONN

202-296-2002

kmack@awhonn.org


###

 

About Nursing for Women's Health

Nursing for Women's Health is a bimonthly refereed clinical practice journal of the Association of Women's Health, Obstetric and Neonatal Nurses. The journal circulates to more than 25,000 nurses who care for women and newborns and is available online at http://nwh.awhonn.org.

 

About AWHONN

Since 1969, the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) has been the foremost authority promoting the health of women and newborns and strengthening the nursing profession through the delivery of superior advocacy, research, education and other professional and clinical resources. AWHONN represents the interests of 350,000 registered nurses working in women's health, obstetric, and neonatal nursing across the United States. Learn more about AWHONN at www.awhonn.org

 

 


BECOME A MEMBER
As a nurse you have the ability to make a difference in your patients’ lives. AWHONN membership provides you with the resources, tools and opportunities to provide the best care to your patients. JOIN NOW
AWHONN'S Store
Purchase our high-quality clinical content through books, live courses, online education, webinars and our groundbreaking line of evidence-based guidelines. PURCHASE NOW
Online Learning Center
The definitive resource for interactive, engaging CNE education through our Postpartum Hemorrhage, Maternal Fetal Triage and POEP online courses, webinars, award-winning journals and much more. ACCESS NOW

 

Association of Women's Health, Obstetric and Neonatal Nurses is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AWHONN is approved by the California Board of Registered Nursing, Provider #CEP580. Accredited status does not imply endorsement by AWHONN or the American Nurses Credentialing Center of any commercial products displayed or discussed in conjunction with educational activities.

Powered by YourMembership  ::  Legal